Compare Stocks

→ This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AEMD Aethlon Medical	$1.51 +2.0%	$1.65	$1.35 ▼ $5.92	$3.88M	1.88	7,818 shs	17,052 shs
INVO INVO Bioscience	$1.30 +4.8%	$1.05	$0.50 ▼ $10.50	$3.40M	1.45	11.91 million shs	606,280 shs
RDGL Vivos	$0.11	$0.07	$0.04 ▼ $0.12	$41.42M	1.53	1.16 million shs	230,748 shs

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AEMD Aethlon Medical	+5.73%	+5.00%	-11.58%	-24.03%	-71.37%
INVO INVO Bioscience	+4.84%	+66.67%	+15.04%	+26.21%	-85.23%
RDGL Vivos	-1.41%	-0.47%	+54.05%	+58.37%	-3.76%

Elon Musk’s Controversial New Project: “Apollo” (Ad)

Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...

Click here to see the details because there's a lot of money at stake.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AEMD Aethlon Medical	1.3101 of 5 stars	3.5	3.0	0.0	0.0	1.1	0.0	0.6
INVO INVO Bioscience	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
RDGL Vivos	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AEMD Aethlon Medical	3.00	Buy	$10.00	561.42% Upside
INVO INVO Bioscience	N/A	N/A	N/A	N/A
RDGL Vivos	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest INVO, AEMD, and RDGL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
3/4/2024	AEMD Aethlon Medical	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$23.00 ➝ $10.00

(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AEMD Aethlon Medical	$570K	6.95	N/A	N/A	$6.56 per share	0.23
INVO INVO Bioscience	$3.02M	1.18	N/A	N/A	($2.06) per share	-0.63
RDGL Vivos	$20K	2,041.57	N/A	N/A	($0.02) per share	-5.25

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AEMD Aethlon Medical	-$12.03M	-$4.99	N/A	N/A	N/A	N/A	-106.28%	-86.60%	6/26/2024 (Estimated)
INVO INVO Bioscience	-$8.03M	-$12.36	N/A	∞	N/A	-459.42%	N/A	-88.87%	5/20/2024 (Estimated)
RDGL Vivos	-$2.89M	N/A	0.00	∞	N/A	-9,524.89%	N/A	-180.12%	5/2/2024 (Estimated)

Latest INVO, AEMD, and RDGL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
3/18/2024	Q4 2023	RDGL Vivos	N/A	-$0.01	-$0.01	-$0.01	N/A	N/A
2/14/2024	Q3 2024	AEMD Aethlon Medical	-$1.23	-$1.37	-$0.14	-$1.37	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AEMD Aethlon Medical	N/A	N/A	N/A	N/A	N/A
INVO INVO Bioscience	N/A	N/A	N/A	N/A	N/A
RDGL Vivos	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AEMD Aethlon Medical	N/A	3.93	3.93
INVO INVO Bioscience	2.94	0.15	0.12
RDGL Vivos	N/A	6.57	6.57

Ownership

Institutional Ownership

Company	Institutional Ownership
AEMD Aethlon Medical	1.99%
INVO INVO Bioscience	12.02%
RDGL Vivos	N/A

Insider Ownership

Company	Insider Ownership
AEMD Aethlon Medical	4.00%
INVO INVO Bioscience	3.50%
RDGL Vivos	18.50%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
AEMD Aethlon Medical	15	2.62 million	2.52 million	Optionable
INVO INVO Bioscience	15	2.74 million	2.65 million	No Data
RDGL Vivos	1	388.87 million	316.93 million	Not Optionable

INVO, AEMD, and RDGL Headlines

Source	Headline
	Vivos Inc RDGL morningstar.com - April 15 at 12:36 AM
	Vivos Therapeutics, Inc: Vivos Therapeutics' Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement finanznachrichten.de - April 11 at 5:24 PM
	Vivos Stock (OTC:RDGL), Quotes and News Summary benzinga.com - March 23 at 12:35 AM
	Vivos Inc thestreet.com - February 23 at 7:06 AM
	3 Stocks to Turn $1,000 Into $1 Million: February 2024 investorplace.com - February 22 at 12:39 PM
	Speculation Tuesday: 2 Call Options and 1 Penny Stock to Consider theglobeandmail.com - January 31 at 1:26 AM
	Vivos: Unregistered Sales Of Equity Securities, Other Events, Financial Statements And Exhibits cbonds.com - December 29 at 9:59 AM
	New Hope In Cancer Battle: FDA Grants Breakthrough Device Status To Vivos Inc.'s RadioGel msn.com - December 21 at 3:43 PM
	Radiogel Precision Radionuclide Therapy Receives FDA Breakthrough Device Designation finance.yahoo.com - December 20 at 1:10 PM
	Radiogel™ Precision Radionuclide Therapy™ Receives FDA Breakthrough Device Designation finance.yahoo.com - December 20 at 1:10 PM
	Vivos Inc. Announces Certification of Three New IsoPet® Precision Radionuclide Therapy Regional Clinics finance.yahoo.com - August 7 at 10:56 AM
	Cupom de desconto Vivo R$119 Off → (4 Cupons Vivo) Junho 2023 catracalivre.com.br - June 21 at 8:15 AM
	GloboNews ao vivo g1.globo.com - May 25 at 10:26 PM
	Vivos Inc. (RDGL) Stock Historical Prices & Data - Yahoo Finance finance.yahoo.com - May 15 at 10:53 PM
	Cupom Vivo - Maio 2023 tecmundo.com.br - May 11 at 10:08 PM
	Isaura ao vivo na Rádio Observador observador.pt - April 29 at 3:54 PM
	Vivo V27 Pro in for review gsmarena.com - February 22 at 11:54 PM
	Três jovens são retirados vivos dos escombros após 8 dias do terremoto na Turquia bemparana.com.br - February 16 at 2:58 PM
	Vivos Inc Files a New Patent on Alternate Particles for Precision Radionuclide Therapy finance.yahoo.com - January 11 at 9:39 AM
	RDGL.PK - Vivos Inc \| Stock Price & Latest News \| Reuters reuters.com - January 5 at 2:29 PM
	Cupom de desconto Vivo Frete Grátis uai.com.br - January 4 at 11:53 PM
	Vivos Inc Files a New Patent on Precision Radionuclide Therapy Support System Equipment finance.yahoo.com - January 3 at 2:06 PM
	Reignite your passion with the vivo Y35 philstar.com - October 12 at 8:10 PM
	Vivo 6 GB RAM mobile phones: The ultimate buyer’s guide hindustantimes.com - October 10 at 5:47 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Aethlon Medical

NASDAQ:AEMD

Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, California.

INVO Bioscience

NASDAQ:INVO

INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. INVO Bioscience, Inc. was founded in 2007 and is based in Sarasota, Florida.

Vivos

OTCMKTS:RDGL

Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States and internationally. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial